| Lavina Jethani, MD | |
|
401 15th Ave Se, Puyallup, WA 98372-3715 | |
| (253) 697-3265 | |
| (931) 208-3645 |
| Full Name | Lavina Jethani |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 8 Years |
| Location | 401 15th Ave Se, Puyallup, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467814475 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Multicare Good Samaritan Hospital | Puyallup, WA | Hospital |
| Tacoma General Allenmore Hospital | Tacoma, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Multicare Health System | 7719899897 | 1704 |
News Archive
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue.
The U.S. Food and Drug Administration today approved a new formulation of the controlled-release drug OxyContin that has been designed to help discourage misuse and abuse of the medication.
Last December, there were only two things 46-year-old Chuck Besen wanted for Christmas… a matching donor heart and kidney. This year, thanks to the SynCardia temporary CardioWest™ Total Artificial Heart and the dual transplant he received at University Medical Center (UMC) in March, Besen will celebrate his first Christmas at home with his 2-year-old son Dylan and his fiancée Jennifer Hokanson.
Stem cells from patients with bipolar disorder are being made available to scientists around the world to boost research into the condition.
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
› Verified 8 days ago
| Entity Name | Multicare Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497766638 PECOS PAC ID: 7719899897 Enrollment ID: O20031105000760 |
News Archive
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue.
The U.S. Food and Drug Administration today approved a new formulation of the controlled-release drug OxyContin that has been designed to help discourage misuse and abuse of the medication.
Last December, there were only two things 46-year-old Chuck Besen wanted for Christmas… a matching donor heart and kidney. This year, thanks to the SynCardia temporary CardioWest™ Total Artificial Heart and the dual transplant he received at University Medical Center (UMC) in March, Besen will celebrate his first Christmas at home with his 2-year-old son Dylan and his fiancée Jennifer Hokanson.
Stem cells from patients with bipolar disorder are being made available to scientists around the world to boost research into the condition.
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lavina Jethani, MD 39 Country View Dr, Freehold, NJ 07728-9019 Ph: (732) 625-0072 | Lavina Jethani, MD 401 15th Ave Se, Puyallup, WA 98372-3715 Ph: (253) 697-3265 |
News Archive
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the researchers filled the nanoparticles with the drug dexamethasone and administered them to mice with inflamed lung tissue.
The U.S. Food and Drug Administration today approved a new formulation of the controlled-release drug OxyContin that has been designed to help discourage misuse and abuse of the medication.
Last December, there were only two things 46-year-old Chuck Besen wanted for Christmas… a matching donor heart and kidney. This year, thanks to the SynCardia temporary CardioWest™ Total Artificial Heart and the dual transplant he received at University Medical Center (UMC) in March, Besen will celebrate his first Christmas at home with his 2-year-old son Dylan and his fiancée Jennifer Hokanson.
Stem cells from patients with bipolar disorder are being made available to scientists around the world to boost research into the condition.
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
› Verified 8 days ago
Sophie Warshaw, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 8011 112th Street Ct E, Puyallup, WA 98373 Phone: 253-848-0662 Fax: 253-848-8567 | |
Keith M. D'souza, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-7900 | |
Terese Brunoff, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1503 W Stewart, Puyallup, WA 98371 Phone: 253-848-6847 | |
Paul B Nutter, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 401 15th Ave Se, Puyallup, WA 98372 Phone: 253-697-2700 | |
Jeffery Thomas Berdan, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1450 5th St Se Ste 4200, Puyallup, WA 98372 Phone: 253-459-7000 | |
John E Benson, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 407 14th Ave Se, Puyallup, WA 98372 Phone: 253-697-1664 |